physostigmine has been researched along with Adenocarcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blandizzi, C; Colucci, R; Danesi, R; De Paolis, B; Del Tacca, M; Di Paolo, A; Falcone, A | 1 |
Hunter, RL; Kirkman, H; Li, JJ | 1 |
2 other study(ies) available for physostigmine and Adenocarcinoma
Article | Year |
---|---|
Cholinergic toxic syndrome by the anticancer drug irinotecan: acetylcholinesterase does not play a major role.
Topics: Acetylcholinesterase; Adenocarcinoma; Aged; Analysis of Variance; Antineoplastic Agents, Phytogenic; Camptothecin; Cholinergic Agents; Cholinesterase Inhibitors; Colorectal Neoplasms; Confidence Intervals; Female; Humans; Irinotecan; Male; Middle Aged; Physostigmine | 2002 |
Sex difference and gonadal hormone influence on Syrian hamster kidney esterase isozymes.
Topics: Acetates; Adenocarcinoma; Animals; Body Weight; Butyrates; Castration; Cricetinae; Electrophoresis; Esterases; Estradiol; Female; Gonadal Steroid Hormones; Gonads; Isoenzymes; Kidney; Kidney Neoplasms; Male; Neoplasms, Experimental; Organ Size; Physostigmine; Progesterone; Sex Factors; Testosterone | 1969 |